XML 42 R25.htm IDEA: XBRL DOCUMENT
v3.5.0.2

The Business (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2016
The Business [Abstract] |
Summary of Principles of Consolidation | The Consolidated Financial Statements include the accounts of Caladrius Biosciences, Inc. and its wholly-owned and partially-owned subsidiaries and affiliates as listed below. All intercompany activities have been eliminated in consolidation.
Entity |  | Percentage of Ownership |  | Location
Caladrius Biosciences, Inc. |  | 100% |  | United States of America
NeoStem Therapies, Inc. |  | 100% |  | United States of America
Stem Cell Technologies, Inc. |  | 100% |  | United States of America
Amorcyte, LLC |  | 100% |  | United States of America
PCT, LLC, a Caladrius Company (1) |  | 80.1% |  | United States of America
NeoStem Family Storage, LLC (1) |  | 80.1% |  | United States of America
Athelos Corporation (2) |  | 97.9% |  | United States of America
PCT Allendale, LLC (1) |  | 80.1% |  | United States of America
NeoStem Oncology, LLC |  | 100% |  | United States of America
_________________________________________________________________ (1) As of June 30, 2016, Hitachi's ownership interest was 19.9% (see Note 3). (2) As of June 30, 2016, Becton Dickinson's ownership interest was 2.1%.

X
- Definition The Business [Abstract] + References No definition available. + Details
Name: | clbs_BusinessAbstract
Namespace Prefix: | clbs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Subsidiary [Table Text Block] + References No definition available. + Details
Name: | clbs_SubsidiaryTableTextBlock
Namespace Prefix: | clbs_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration